Sigachi Industries Reports Q2 Revenue Of ₹130 Crore And Net Profit Of ₹10.2 Crore

Market snapshot: Sigachi Industries Limited reported its second-quarter consolidated financial results, highlighting expanded operational profitability alongside topline growth. Consolidated revenue for the quarter reached ₹130 crore, supported by a significant margin expansion in operating EBITDA.

Data Snapshot

• Q2 consolidated revenue rose to ₹130 crore from ₹110 crore YoY, reflecting growth of ≈18.18% YoY (derived: ₹130 crore vs ₹110 crore).
• Q2 consolidated net profit recorded at ₹10.2 crore compared to ₹10.7 crore YoY, down ≈4.67% YoY (derived: ₹10.2 crore vs ₹10.7 crore).
• Q2 EBITDA surged to ₹18.8 crore from ₹7.5 crore YoY, marking growth of ≈150.67% YoY (derived: ₹18.8 crore vs ₹7.5 crore).
• Q2 EBITDA margin widened by 760 bps YoY to reach 14.42% compared to 6.82% in the prior-year quarter.

What's Changed

• Revenue expanded from ₹110 crore to ₹130 crore on a year-on-year basis.
• Operating profitability showed significant operational leverage, with EBITDA jumping to ₹18.8 crore from ₹7.5 crore.
• EBITDA margin increased by 760 basis points to 14.42% from 6.82%.
• Net profit moderated slightly to ₹10.2 crore from ₹10.7 crore in Q2 of the previous fiscal.

Key Takeaways

• Topline momentum remained firm with consolidated revenue expanding to ₹130 crore.
• Operational efficiency improved markedly as EBITDA more than doubled year-on-year to ₹18.8 crore.
• Operating margins expanded to 14.42%, signaling cost control and favorable product mix execution.
• Bottom-line profit remained essentially flat YoY at ₹10.2 crore due to higher overhead and non-operating adjustments.

SAHI Perspective

Sigachi Industries' Q2 performance reflects substantial progress in operating profitability. While bottom-line expansion was constrained by non-operating costs, the 760 bps expansion in EBITDA margin to 14.42% underscores strengthening execution across core microcrystalline cellulose and formulation verticals.

Market Implications

The strong expansion in operating EBITDA provides operational support for the stock, though market reaction may remain balanced given that net profit was capped at ₹10.2 crore. Sustained margin performance in subsequent quarters will be key to re-rating momentum.

Trading Signals

Market Bias: Bullish

Strong operational leverage highlighted by EBITDA surging to ₹18.8 crore and margins expanding to 14.42% provides strong structural support, offsetting flat net profit performance.

Overweight: Pharmaceutical Excipients, Speciality Chemicals

Trigger Factors:

• Sustained quarterly revenue generation above ₹130 crore
• EBITDA margin retention above the 14% threshold
• Net profit recovery toward double-digit growth trajectory

Time Horizon: Near-term (0-3 months)

Industry Context

The pharmaceutical excipients and speciality chemical sectors rely on operational efficiency and volume scale to protect margins against shifting raw material prices. Sigachi's capacity positioning across its manufacturing units allows it to capture operating leverage as throughput increases.

Key Risks to Watch

• Raw material price volatility affecting pre-formulation input costs
• Non-operating expense inflation limiting net profit conversion
• Regulatory compliance requirements across global export markets

Recent Developments

Sigachi Industries held its 37th Annual General Meeting in September 2026 to present audited financials and corporate updates. In August 2026, the company reported Q1 FY27 net profit of ₹8.14 crore during its quarterly investor briefing.

Closing Insight

Sigachi Industries demonstrates solid operational discipline with expanding operating margins, placing the company in a strong position to convert revenue growth into durable operating cash flows.

High Performance Trading with SAHI.